Total Payments
$20,645
2024 Payments
$1,494
Companies
18
Transactions
59
Medicare Patients
5,370
Medicare Billing
$862,651
Payment Breakdown by Category
Consulting$15,787 (76.5%)
Food & Beverage$4,570 (22.1%)
Travel$289.30 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $15,787 | 10 | 76.5% |
| Food and Beverage | $4,570 | 46 | 22.1% |
| Travel and Lodging | $289.30 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ferring Pharmaceuticals Inc. | $13,529 | 7 | $0 (2019) |
| Photocure Inc | $3,277 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $798.52 | 3 | $0 (2024) |
| Genentech, Inc. | $435.19 | 4 | $0 (2019) |
| UROGEN PHARMA, INC. | $403.90 | 3 | $0 (2024) |
| Intuitive Surgical, Inc. | $303.30 | 4 | $0 (2021) |
| Janssen Research & Development, LLC | $280.00 | 5 | $0 (2023) |
| Janssen Biotech, Inc. | $272.87 | 3 | $0 (2024) |
| KARL STORZ Endoscopy-America | $210.34 | 2 | $0 (2022) |
| Seagen Inc. | $176.27 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,494 | 8 | AstraZeneca Pharmaceuticals LP ($798.52) |
| 2023 | $585.97 | 6 | Janssen Research & Development, LLC ($180.00) |
| 2022 | $2,215 | 11 | Photocure Inc ($1,594) |
| 2021 | $303.30 | 4 | Intuitive Surgical, Inc. ($303.30) |
| 2019 | $14,233 | 14 | Ferring Pharmaceuticals Inc. ($13,529) |
| 2018 | $610.61 | 5 | Photocure Inc ($499.53) |
| 2017 | $1,204 | 11 | Photocure Inc ($658.56) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $697.50 | General |
| 07/15/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $214.55 | General |
| Category: UROTHELIAL CANCER | ||||||
| 06/05/2024 | Axonics, Inc. | Bulkamid (Device), Axonics | Food and Beverage | In-kind items and services | $139.53 | General |
| Category: Urology | ||||||
| 05/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $105.91 | General |
| Category: Oncology | ||||||
| 05/02/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $192.84 | General |
| Category: ONCOLOGY | ||||||
| 01/26/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $76.02 | General |
| Category: Oncology | ||||||
| 01/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $42.26 | General |
| Category: Oncology | ||||||
| 01/26/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 12/02/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $93.50 | General |
| Category: Oncology | ||||||
| 11/30/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $149.21 | General |
| Category: Oncology | ||||||
| 11/29/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/29/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/29/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 04/28/2023 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $163.26 | General |
| Category: ONCOLOGY | ||||||
| 12/14/2022 | Photocure Inc | CYSVIEW (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $67.24 | General |
| Category: UROTHELIAL CANCER | ||||||
| 12/01/2022 | EDAP TECHNOMED INC | — | Food and Beverage | Cash or cash equivalent | $171.12 | General |
| 11/19/2022 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $82.77 | General |
| Category: Oncology | ||||||
| 11/01/2022 | UroGen Pharma, Inc. | — | Food and Beverage | In-kind items and services | $122.11 | General |
| 10/31/2022 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: ONCOLOGY | ||||||
| 08/31/2022 | Photocure Inc | CYSVIEW (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: ONCOLOGY | ||||||
| 05/13/2022 | KARL STORZ Endoscopy-America | — | Food and Beverage | In-kind items and services | $77.68 | General |
| 05/13/2022 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $67.97 | General |
| Category: ONCOLOGY | ||||||
| 01/12/2022 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 01/12/2022 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $50.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,694 | 5,441 | $2.5M | $254,066 |
| 2022 | 29 | 1,210 | 3,893 | $2.4M | $242,949 |
| 2021 | 31 | 1,258 | 7,194 | $809,651 | $211,241 |
| 2020 | 35 | 1,208 | 2,066 | $704,625 | $154,395 |
Total Patients
5,370
Total Services
18,594
Medicare Billing
$862,651
Procedure Codes
125
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 311 | 477 | $436,455 | $81,542 | 18.7% |
| 51999 | Other procedure on bladder using an endoscope | Facility | 2023 | 21 | 21 | $741,532 | $26,843 | 3.6% |
| A9589 | Instillation, hexaminolevulinate hydrochloride, 100 mg | Office | 2023 | 16 | 16 | $72,960 | $15,590 | 21.4% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 65 | 65 | $86,963 | $15,356 | 17.7% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 17 | 17 | $176,000 | $13,400 | 7.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 83 | 83 | $61,005 | $12,893 | 21.1% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 42 | 48 | $75,869 | $10,334 | 13.6% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2023 | 50 | 51 | $92,375 | $9,114 | 9.9% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 47 | 3,451 | $42,868 | $7,598 | 17.7% |
| 52240 | Destruction and/or removal of large growth of bladder using an endoscope | Facility | 2023 | 24 | 24 | $81,215 | $7,213 | 8.9% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 114 | 119 | $39,032 | $6,837 | 17.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 45 | $23,625 | $6,032 | 25.5% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 57 | 89 | $111,873 | $5,916 | 5.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 61 | $20,435 | $5,839 | 28.6% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2023 | 18 | 18 | $107,184 | $4,819 | 4.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $20,710 | $4,799 | 23.2% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 35 | 39 | $78,904 | $3,435 | 4.4% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Facility | 2023 | 16 | 18 | $63,490 | $2,598 | 4.1% |
| 51705 | Simple change of bladder tube | Office | 2023 | 20 | 34 | $15,742 | $2,344 | 14.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 275 | 282 | $31,866 | $2,169 | 6.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 23 | $5,290 | $1,618 | 30.6% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 159 | 160 | $76,321 | $1,550 | 2.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 19 | 30 | $12,840 | $1,361 | 10.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 22 | 30 | $5,850 | $1,162 | 19.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 18 | $4,860 | $1,112 | 22.9% |
About Dr. Mark Tyson, M.D
Dr. Mark Tyson, M.D is a Urology healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2010. The National Provider Identifier (NPI) number assigned to this provider is 1346568508.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Tyson, M.D has received a total of $20,645 in payments from pharmaceutical and medical device companies, with $1,494 received in 2024. These payments were reported across 59 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($15,787).
As a Medicare-enrolled provider, Tyson has provided services to 5,370 Medicare beneficiaries, totaling 18,594 services with total Medicare billing of $862,651. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Scottsdale, AZ
- Active Since 05/12/2010
- Last Updated 09/10/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1346568508
Products in Payments
- CYSVIEW (Drug) $1,950
- Cysview (Drug) $1,327
- Da Vinci Surgical System (Device) $303.30
- JELMYTO (Drug) $281.79
- TECENTRIQ (Biological) $229.11
- PADCEV (Biological) $176.27
- Nubeqa (Drug) $149.21
- ERLEADA (Drug) $148.17
- Bulkamid (Device) $139.53
- FLEX-XC CMOS URETEROSCOPE 8.5 FR X 675MM (Device) $132.66
- ZYTIGA (Drug) $124.70
- Axumin (Drug) $116.21
- Non-Covered Product (Drug) $111.08
- IMFINZI (Biological) $101.02
- XTANDI (Drug) $100.06
- KEYTRUDA (Biological) $100.00
- PROVENGE (Drug) $75.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Scottsdale
Suzette Sutherland, M.d, M.D
Urology — Payments: $276,266
Urology $276,266
Dr. Thayne Larson, Md, MD
Urology — Payments: $47,594
Urology $47,594
Lipika Mccauley, M.d, M.D
Urology — Payments: $44,314
Urology $44,314
Dr. Michael Zell, Md, MD
Urology — Payments: $40,943
Urology $40,943
Anojan Navaratnam, Mbbs, MBBS
Urology — Payments: $30,357
Urology $30,357
Dr. Matthew Steinway, M.d, M.D
Urology — Payments: $24,884
Urology $24,884